OPGENORTH PAUL HIDEO

PrivateCIK: 2033517
Location

GLENDALE, CA

OPGENORTH PAUL HIDEO enters EXOZYMES INC. with 638.16K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderOPGENORTH PAUL HIDEOCIK 2033517
IssuerEXOZYMES INC.CIK 2010788
Officer· Vice President, Development
Since Nov 2024
638.16K
Baseline shares
100% direct
638.16K
Direct ownership
1 position
115.91K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Stock

Direct
Shares owned638.16K
Total
638.16K direct638.16K
Derivative Holdings4

Stock Options for Common Stock

Direct
Underlying security
Common Stock

Underlying shares

38.95K

Shares owned

N/A

Exercise price

2.44

Expiration

Exercise window

Restricted Stock Units for Common Stock

Direct
Underlying security
Common Stock

Underlying shares

21.89K

Shares owned

N/A

Exercise price

3.32

Expiration

Exercise window

Restricted Stock Units for Common Stock

Direct
Underlying security
Common Stock

Underlying shares

52.72K

Shares owned

N/A

Exercise price

2.44

Expiration

Exercise window

SAFE for Common Stock

Direct
Underlying security
Common Stock

Underlying shares

2.34K

Shares owned

N/A

Exercise price

6.40

Expiration

Exercise window

Total

Underlying

115.91K

Owned

0.00

OPGENORTH PAUL HIDEO — Initial Ownership Disclosure (Form 3) Filed Nov 18, 2024 | Finecho